Onderzoeker
Astrid Van den Eynde
- Trefwoorden:Geneeskunde
- Disciplines:Kankertherapie, Gastro-enterologie
Affiliaties
- Centrum voor Oncologisch Onderzoek (CORE) (Onderzoeksgroep)
Lid
Vanaf15 okt 2019 → Heden
Projecten
1 - 1 of 1
Publicaties
1 - 4 van 4
- IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts(2024)
Auteurs: Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, Ho Wa Lau, Christophe Hermans, Hilde Lambrechts, Tal Flieswasser, Delphine Quatannens, Gils Roex, Karen Zwaenepoel, et al.
Pagina's: 1 - 19 - Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer(2023)
Auteurs: Tal Flieswasser, Astrid Van den Eynde, Laurie Freire Boullosa, Jöran Melis, Christophe Hermans, Céline Merlin, Ho Wa Lau, Jonas Van Audenaerde, Filip Lardon, Evelien Smits, et al.
Pagina's: 1 - 11 - The CD70-CD27 axis in oncology(2022)
Auteurs: Tal Flieswasser, Astrid Van den Eynde, Jonas Van Audenaerde, Jorrit De Waele, Filip Lardon, Carsten Riether, Hans de Haard, Evelien Smits, Patrick Pauwels, Julie Jacobs
- Clinically relevant chemotherapeutics have the ability to induce immunogenic cell death in non-small cell lung cancer(2020)
Auteurs: Tal Flieswasser, Jinthe Van Loenhout, Laurie Freire Boullosa, Astrid Van den Eynde, Jorrit De Waele, Jonas Van Audenaerde, Filip Lardon, Evelien Smits, Patrick Pauwels, Julie Jacobs
Patenten
1 - 1 van 1
- Cell-based therapeutics targeting CD70 (Inventor)